Last updated: 2026-09-07 16:35:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Generation Bio Co (GBIO) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
Generation Bio Co (GBIO) last closed at $-- as of --, -- from the previous close of $--.
During the latest regular trading session, GBIO traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.
Over the past seven days, Generation Bio Co (GBIO) moved from $5.53 to $5.34, representing a decline of 3.44% ($0.19).
The stock traded between $5.34 and $5.77 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 174.50 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 115 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Generation Bio Co (GBIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.